INFY has lost 10% in a single week and nearly 12% over the past month — a sharp deterioration that accelerated after the June 23 earnings print landed below market expectations.
The stock closed at ₹1,029.30 on June 23, down 3.4% on the day and now trading roughly 35% below the levels where founder-family associates were selling aggressively last December. That divergence is worth noting: the Shibulal family sold shares worth over $35 million at prices around ₹1,585 in December 2025. The stock has since shed a third of that value. The most recent insider activity cuts the other way — Chairman Nandan Nilekani bought 6,400 shares at ₹1,159.90 in late May, a modest but directionally notable purchase from someone with intimate knowledge of the business. CEO Salil Parekh sold 95,800 shares at ₹1,178 earlier in May, a larger move in rupee terms (~$1.2 million equivalent), though executive share sales at Indian IT firms are often plan-driven rather than discretionary.
The post-earnings reaction pattern has been consistently painful. The April 23 print triggered a 9% single-day decline and the stock was still down nearly 7% five days later — one of the sharper earnings-day reactions in the peer group. The June 23 event slot appears in the data without a confirmed price move attached yet, but the weekly and monthly declines embed most of the damage. The next earnings date is flagged for July 23, arriving quickly after the current selloff, which leaves little recovery runway before investors must again weigh guidance.
Peers confirm this is partly a sector story, but INFY is underperforming within it. TCS fell 6.3% on the week and HCLTECH dropped 4.3% — meaningful declines, but both are holding up better than INFY's near-10% weekly slide. COFORGE was the standout exception, actually gaining 1.1% on the week, suggesting selective demand remains intact for mid-cap names with cleaner growth profiles. The Indian IT services cohort is clearly repricing for a softer demand environment, but Infosys is absorbing a disproportionate share of the selling pressure.
Valuation has compressed meaningfully but has not yet reached distressed territory. The trailing P/E has dropped by roughly 1.6 turns over the past 30 days to around 13.2x, and price-to-book has shed half a point to 4.2x over the same period. These are below recent norms for a franchise of this quality — the ORTEX factor score gives Infosys a 99th-percentile dividend rank and flags solid quality fundamentals, including an ROA near 15% and healthy free cash flow margins. The tension is that quality scores age slowly while momentum scores move fast: the 30-day EPS momentum rank has slipped to the 27th percentile, and EPS surprise sits at just the 19th percentile, reflecting a pattern of guidance cuts and missed expectations rather than beats.
The borrow market has normalised materially since the pre-earnings squeeze described in last week's note, with utilization back at zero across the full 30-day history window — no meaningful short-selling demand in the lending pool. What's worth watching now is whether the post-print selloff attracts fresh institutional buying at these compressed multiples, or whether the next five weeks into the July 23 earnings date become another period of grinding attrition for a stock that has already absorbed nearly four months of consecutive losses.
See the live data behind this article on ORTEX.
Open INFY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
